As of 2026-10-05, the EV/EBITDA ratio of Oncternal Therapeutics Inc (ONCT) is 0.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ONCT's latest enterprise value is -11.52 mil USD. ONCT's TTM EBITDA according to its financial statements is -35.96 mil USD. Dividing these 2 quantities gives us the above ONCT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 16.0x | 15.6x |
| Forward P/E multiples | 17.0x - 19.6x | 18.4x |
| Fair Price | (202.35) - (189.95) | (202.10) |
| Upside | -38524.9% - -36171.9% | -38478.8% |
| Date | EV/EBITDA |